Estrogen has been reported to have both short- and long-term effects on the cardiovascular system. However, it remains to be examined how short-term transdermal estrogen therapy (TET) affects insulin sensitivity (SI) in patients with cardiac syndrome X (CSX), who are characterized by elevated insulin resistance. SI was assessed in a randomized, double-blind, placebo-controlled crossover study by minimal model analysis in seven postmenopausal women with CSX treated by TET. SI decreased by 32 ± 8.3%, from 5.94 ± 1.14 at baseline to 3.61 ± 0.40 [(10–4 × min–1)/(µU/ml)] during TET (p = 0.03). Time to the onset of symptoms increased from 414.2 ± 51.0 s at baseline to 450.0 ± 53.2 s (p = 0.04). We conclude that TET increases SI in postmenopausal women with CSX. This effect is unrelated to the beneficial anti-ischemic effects on exercise duration.

Keywords:
Insulin resistance, Estrogen replacement therapy, Cardiac syndrome X
1.
Maseri A, Crea F, Kaski JC, Crake T: Mechanisms of angina pectoris in syndrome X. J Am Coll Cardiol 1991;17:499–506.
2.
Cannon RO, Epstein SE: ‘Microvascular angina’ as a cause of chest pain with angiographically normal coronary arteries. Am J Cardiol 1988;61:1338–1343.
3.
Rosano GMC, Collins P, Kaski JC, Lindsay DC, Sarrel PM, Poole-Wilson PA: Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 1995;16:610–614.
4.
Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P: Beneficial effects of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993;342:133–136.
5.
Rosano GMC, Peters NS, Lefroy D, et al: 17-Beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 1996;28:1500–1505.
6.
Roqué M, Heras M, Roig E, et al: Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 1998;31:139–143.
7.
Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999;340:1801–1811.
8.
Moller DE, Flier JS: Insulin resistance – mechanisms, syndromes, and implications. N Engl J Med 1991;325:938–948.
9.
Assali A, Beigel Y, Schreibman R, Shafer Z, Fainaru M: Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol 1999;22:357–360.
10.
Reaven GM: Role of insulin resistance in human disease. Diabetes 1988;37:1595–1607.
11.
Després JP, Lamarche B, Mauriège P, et al: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 1996;334:952–957.
12.
Botker HE, Frobert O, Moller N, Christiansen E, Schmitz O, Bagger JP: Insulin resistance in cardiac syndrome X and variant angina: Influence of physical capacity and circulating lipids. Am Heart J 1997;134:229–237.
13.
Gaspardone A, Ferri C, Crea F, et al: Enhanced activity of sodium-lithium countertransport in patients with cardiac syndrome X: A potential link between cardiac and metabolic syndrome X. J Am Coll Cardiol 1998;132:2031–2034.
14.
Botker HE, Moller N, Ovesen P, et al: Insulin resistance in microvascular angina (syndrome X). Lancet 1993;342:136–140.
15.
Welch S, Gebhart SSP, Bergman RN, Phillips LS: Minimal model analysis of intravenous glucose tolerance test-derived insulin sensitivity in diabetic subjects. J Clin Endocrinol Metab 1990;71:1508–1518.
16.
O’Sullivan AJ, Ho KK: A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women. J Clin Endocrinol Metab 1995;80:1783–1788.
17.
Duncan AC, Lyall H, Roberts RN, et al: The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women. J Clin Endocrinol Metab 1999;84:2402–2407.
18.
Cagnacci A, Soldani R, Carriero PL, Paoletti AM, Fioretti P, Melis GB: Effects of low doses of transdermal 17-beta-estradiol on carbohydrate metabolism in postmenopausal women. J Clin Endocrinol Metab 1992;74:1396–1400.
19.
Cagnacci A, Tuveri F, Cirillo R, Setteneri AM, Melis GB, Volpe A: The effect of transdermal 17-beta-estradiol on glucose metabolism of postmenopausal women is evident during the oral but not the intravenous glucose administration. Maturitas 1997;28:163–167.
20.
Godsland IF, Gangar K, Walton C, et al: Insulin resistance, secretion, and elimination in postmenopausal women receiving oral or transdermal hormone replacement therapy. Metabolism 1993;42:846–853.
21.
Kimmerle R, Heinemann L, Heise T, et al: Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women. Menopause 1999;6:36–42.
22.
Hemminiki E, McPherson K: Impact of postmenopausal hormone therapy on cardiovascular events and cancer: Pooled data from clinical trials. BMJ 1997;315:149–153.
23.
Hulley S, Grady D, Bush T, et al: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. JAMA 1998;280:605–613.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.